Beth Israel Deaconess Medical Center

New Capabilities

Home of the Berenson-Allen Center, which produced the circuit map tested in the trial

Forty people with treatment-resistant depression received the same accelerated brain stimulation schedule. The only difference was where the magnetic pulses landed. One month later, 80% of those whose target came from their own fMRI scan responded, against 60% of those targeted by scalp measurement.

Updated 3 days ago

New Capabilities

Research partner to NeuroXT

For years, software that reads a brain scan has been cleared to report what is visible now: a bleed, a lesion, a narrowed vessel. NEXT-Cue is cleared to report something else — how likely a patient already diagnosed with mild cognitive impairment is to develop Alzheimer's dementia within five years.

Updated Nov 1

Built World

Dana-Farber's new inpatient partner

Dana-Farber Cancer Institute broke ground on Oct. 19 on a 300-bed hospital built solely for cancer patients, the first inpatient facility of its kind in the Boston region. The $1.68 billion Lavine Bekenstein Cancer Hospital, set to open in 2031 on the former Joslin Diabetes Center site, will have 30 intensive care beds and four floors with specialized air protection for patients with weakened immune systems.

Updated Oct 20